Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00453674 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

German Adrenocortical Carcinoma Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint added 0 → 1 primary endpoints
See other at-risk trials from University of Wuerzburg

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
    • Primary and study completion dates: Dec 2030 to Dec 31, 2030
    • Start date: Jan 2003 to Jan 1, 2003
    v17
  2. 5 versions Re-verified since May 9, 2023, no change to tracked fieldsv12-v16
  3. Publications: 14 to 19v11
  4. Primary completion date: Dec 2023 to Dec 2030
    • Study completion date: Dec 2025 to Dec 2030
    v10
  5. 2 versions Re-verified since Oct 28, 2016, no change to tracked fieldsv8-v9
Show 6 earlier versionsHide 6 earlier versions
  1. Primary completion date: Dec 2023
    • Study completion date: Dec 2012 to Dec 2025
    • Publications: 1 to 14
    v7
  2. Enrollment target: 600 to 1000
    • Study completion date: Dec 2011 to Dec 2012
    v6
  3. Study completion date: Dec 2010 to Dec 2011v5
  4. 3 versions Re-verified since Sep 12, 2007, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.
Trial Details
NCT Number NCT00453674
Lead Sponsor University of Wuerzburg
Collaborators: Deutsche Krebshilfe e.V., Bonn (Germany)
Conditions
(from sponsor)		 Adrenocortical Carcinoma
Related terms Adrenal Gland Neoplasms, Adrenocortical Carcinoma
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov